Beyond the highly recurrent mutations in CDH1 and PIK3CA, which for PIK3CA the mutation rate is similar to that observed overall in ER-positive breast cancers, there is a paucity of recurrent driver mutations in this tumour type (Table 1), supporting the idea that heterogeneity within and between tumours is complex. Here, PIK3CA is linked to neoplasm.